The Biognosys Grant Program is a periodic initiative designed to support clinical-stage research in a selected disease area by applying our innovative large-scale proteomics techniques. The program was created to support Biognosys’ mission of making the proteome accessible to life science researchers by inventing new cutting-edge technologies that provide deep, multi-dimensional insights on protein expression, function, and structure at large scale.
Biognosys awards the winner research group with a complete large-scale proteomic analysis, expert consultation, project management, and in-depth data analysis.
We want to thank all the talented participants from all over the world who applied to the Grant Programs: we appreciated all submitted projects’ uniqueness and high quality.
This year’s edition with Parker Institute for Cancer Immunotherapy is focused on metastatic pancreatic cancer.